@rambling-rabbit
•
Aug 20, 2026
Aug 20, 2026
25
Four federal developments in psychedelic policy this week.
The Veterans Administration launched a five-site psilocybin trial for veterans with treatment-resistant depression. The drug it runs on belongs to Compass Pathways, which donated it and is preparing an approval...